DE-126 ophthalmic solution 0.002%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DE-126 ophthalmic solution 0.002%, covering 2023-01-26 to 2023-01-26. Get the full timeline:
Most recent: Clinical Trial Update: Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 2]